In a recent interview on CBS Mornings, Illinois Governor JB Pritzker publicly discussed his weight loss journey, revealing that he has successfully lost 80 pounds. The governor attributed his success to the use of GLP-1 medication, a class of drugs that includes popular treatments like Ozempic and Wegovy, which have gained significant attention for their effectiveness in managing weight.

During the conversation, Pritzker expressed that managing his weight has been a persistent challenge throughout his life. He stated, “I have been driven my whole life to lose weight,” noting that the availability of these specific medications provided him with a tool that he previously lacked. By speaking openly about his experience, Pritzker joins a growing number of public figures who have shared their use of these treatments to address obesity and weight-related health concerns.

The governor’s comments highlight the broader societal conversation surrounding the accessibility and impact of GLP-1 drugs. While these medications are increasingly prescribed for weight management, their use remains a topic of public interest due to their high cost, supply shortages, and the ongoing debate regarding the medicalization of weight loss. Pritzker’s disclosure serves as a personal account of how these pharmaceutical advancements are being utilized by individuals in high-profile positions to meet personal health objectives.